Miembros de la Junta Directiva

Joe Kiani is the Founder and Executive Chairman of Willow Laboratories, a health and wellness innovator dedicated to advancing noninvasive monitoring solutions and reinventing diabetes care. Prior to Willow, Kiani founded Masimo in 1989 and led it from a garage startup to a publicly traded medical technology company with over $2 billion in revenue. He holds more than 600 patents and co-invented measure-through-motion pulse oximetry. His technology is used to monitor over 200 million patients annually. He also founded the Patient Safety Movement Foundation to help eliminate preventable hospital deaths. Kiani is co-founder and CEO of Like Minded Labs, a media technology company reimagining virtual collaboration. In addition, he serves as Chairman of Clarity, a breast cancer-focused medtech company, and SMS Biotech, which is democratizing adult stem cell technologies for human health, and is an investor and board member at CDX Medical Technologies (a pioneer in ECMO pump innovation), MY01 (transforming diagnosis of limb perfusion injuries), and IRAMED (a leader in MRI-compatible patient monitoring and infusion systems).

Dr. Jill Biden is an American educator, author, and former First Lady of the United States. She has spent much of her life in the classroom, teaching English, writing, and reading at the high school and community college levels. She earned a Doctor of Education degree from the University of Delaware, reflecting her deep commitment to teaching and student success. Throughout her public life, Dr. Biden has been a strong advocate for education, community colleges, military families, and expanded opportunities for women and children. As Second Lady and later First Lady of the United States, she continued teaching while also using her platform to support students, educators, service members, veterans, and working families. Known for balancing public service with her career as an educator, Dr. Biden has emphasized the importance of compassion, resilience, and lifelong learning. In addition to her work in education, Dr. Biden has been an active advocate for healthcare causes, particularly cancer prevention, early detection, and women’s health. Her advocacy began with the Biden Breast Health Initiative, which educated young women about breast health and cancer awareness. As First Lady, she continued this work through the Cancer Moonshot initiative, supporting efforts to improve cancer screening, patient navigation, and family-centered care. She has also championed women’s health research, helping bring national attention and federal investment to areas of medicine that have historically been underfunded.

Ken Buck graduated from Princeton University in 1981 and the University of Wyoming Law School in 1985. After law school, Ken worked for Congressman Dick Cheney (R-WY) on the Iran-Contra Investigation and then became a prosecutor with the U.S. Department of Justice. In 1990, Ken joined the Colorado U.S. Attorney’s Office where he became the Chief of the Criminal Division. During his tenure as a federal prosecutor, Ken taught as an Adjunct Law Professor.

Mohamed Diab is an accomplished technology leader in the medical device field, bringing decades of expertise in non-invasive sensing and physiological monitoring to guide Willow Laboratories’ research, development, and product innovation. With an extensive patent portfolio spanning multi-wavelength sensors, alarm systems, and advanced non-invasive analytical devices, he leads cross-functional teams in engineering, product design, and regulatory strategy. A graduate of California State University, Fullerton, Diab previously held senior technical leadership roles at Masimo Corporation. As CTO, he advances Willow’s mission to deliver breakthrough medical technologies that enhance patient care and extend healthspan through safety, accuracy, and scalability.

Said Hilal ha sido el director ejecutivo de Applied Medical desde su fundación en 1987. Como empresa de dispositivos médicos de nueva generación, Applied Medical utiliza la innovación en el diseño, el desarrollo y los procesos para mejorar los resultados clínicos y, al mismo tiempo, reducir el coste de la atención médica.

Sarah Kiani es una defensora global comprometida con la equidad en salud, la seguridad del paciente, la protección del medio ambiente y el bienestar comunitario. Con un profundo compromiso para mejorar la salud de las personas, los animales y el planeta, Sarah ha impulsado iniciativas que reflejan compasión y un impacto real.

Parag Saxena is a Founding General Partner and CEO of New Silk Partners a USD 1.383 billion fund founded in 2007 focused on making investments in India and the sub-continent. He is also co-founded Vedanta Capital LLC a U.S. venture capital firm founded in 2006. Previously, he was CEO of INVESCO Private Capital, one of the world’s oldest and largest independent asset management companies. During the course of his 23-year tenure at INVESCO, the firm and its predecessors made over 300 investments, including Amgen, Costco, PictureTel, Polycom, Staples and Starbucks. He was responsible for both direct and fund of funds investment activities where he led over $8 USD billion in peak assets. At INVESCO Private Capital, he led over 90 investments, a third of which went on to become public companies. These include, Alkermes, Celgene, Genomic Health, Indigo, Masimo, Transgenomic, Xenon Pharmaceuticals, Amber Networks, ARM Holdings, MetroPCS and Volterra.